- Corporate Officers - K
- Kozarich John W
Insider Trading History of Kozarich John W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kozarich John W since 2015.
This trader's CIK number is 1223000.
At the time of last reporting, Kozarich John W was the Director of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
Note that in the past
KOZARICH JOHN W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Intec Pharma Ltd. (NTEC) by Kozarich John W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | NTEC | 100,000 | $45,900 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Novelion Therapeutics Inc. (QLTI) by Kozarich John W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | QLTI | 0 | $0 | 0 | $0 | 35,000 | $87,125 |
Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Kozarich John W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LGND | 0 | $0 | 1,868 | $254,344 | 2,406 | $125,833 |
| 2024 | LGND | 0 | $0 | 0 | $0 | 2,893 | $113,839 |
| 2023 | LGND | 0 | $0 | 10,852 | $835,241 | 6,408 | $120,598 |
| 2021 | LGND | 0 | $0 | 0 | $0 | 7,335 | $74,229 |
| 2019 | LGND | 0 | $0 | 2,500 | $282,300 | 2,500 | $44,700 |
| 2018 | LGND | 0 | $0 | 10,000 | $1,969,872 | 0 | $0 |
| 2017 | LGND | 0 | $0 | 5,000 | $708,550 | 0 | $0 |
| 2016 | LGND | 0 | $0 | 13,332 | $1,522,722 | 1,666 | $98,960 |
Insider trading activities at 3 companies by Kozarich John W:
1. Intec Pharma Ltd. (NTEC)
2. Novelion Therapeutics Inc. (QLTI)
3. Ligand Pharmaceuticals Inc (LGND)
Table 1. Insider trading of Intec Pharma Ltd. (NTEC) by Kozarich John W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-08-23 | NTEC | Buy | 100,000 | .46 | 45,900 |
Table 2. Insider trading of Novelion Therapeutics Inc. (QLTI) by Kozarich John W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-29 | QLTI | Option Ex | 25,000 | 3.48 | 87,125 |
| 2015-06-07 | QLTI | Option Ex | 10,000 | .00 | 0 |
Table 3. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Kozarich John W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-02 | LGND | Sale | 467 | 162.76 | 76,008 |
| 2025-08-01 | LGND | Sale | 467 | 131.88 | 61,586 |
| 2025-07-10 | LGND | Sale | 934 | 125.00 | 116,750 |
| 2025-01-17 | LGND | Option Ex | 2,406 | 52.30 | 125,833 |
| 2024-04-24 | LGND | Option Ex | 2,893 | 39.35 | 113,839 |
| 2023-05-16 | LGND | Sale | 4,444 | 77.20 | 343,081 |
| 2023-05-08 | LGND | Sale | 6,408 | 76.80 | 492,160 |
| 2023-05-08 | LGND | Option Ex | 6,408 | 18.82 | 120,598 |
| 2021-05-11 | LGND | Option Ex | 4,835 | 10.12 | 48,930 |
| 2021-02-22 | LGND | Option Ex | 2,500 | 10.12 | 25,299 |
| 2019-05-14 | LGND | Option Ex | 2,500 | 17.88 | 44,700 |
| 2019-05-14 | LGND | Sale | 2,500 | 112.92 | 282,300 |
| 2018-10-01 | LGND | Sale | 2,500 | 275.04 | 687,610 |
| 2018-07-02 | LGND | Sale | 2,500 | 207.48 | 518,700 |
| 2018-04-02 | LGND | Sale | 2,500 | 160.43 | 401,062 |
| 2018-01-10 | LGND | Sale | 2,500 | 145.00 | 362,500 |
| 2017-11-16 | LGND | Sale | 5,000 | 141.71 | 708,550 |
| 2016-09-07 | LGND | Sale | 1,000 | 115.00 | 115,000 |
| 2016-09-01 | LGND | Sale | 1,666 | 105.23 | 175,319 |
| 2016-08-01 | LGND | Sale | 1,000 | 137.80 | 137,800 |
| 2016-07-01 | LGND | Sale | 1,000 | 121.08 | 121,080 |
| 2016-06-01 | LGND | Sale | 1,000 | 118.33 | 118,335 |
| 2016-05-02 | LGND | Sale | 1,000 | 121.75 | 121,745 |
| 2016-04-06 | LGND | Sale | 5,000 | 115.00 | 575,000 |
| 2016-01-20 | LGND | Option Ex | 1,666 | 59.40 | 98,960 |
| 2016-01-20 | LGND | Sale | 1,666 | 95.10 | 158,443 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kozarich John W
(Director of Ligand Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.